No Data
The Three-year Earnings Decline Is Not Helping Jointown Pharmaceutical Group's (SHSE:600998 Share Price, as Stock Falls Another 4.1% in Past Week
Jiuzhoutong Pharmaceutical Receives CSRC Approval for REITs
Jointown Pharmaceutical Group (600998.SH): A subsidiary has received the approval notice for the listing application of Chemical Raw Materials.
On December 20, 2023, Jointown Pharmaceutical Group (600998.SH) announced that its holding subsidiary, Peking Jingfeng Pharmaceutical (ShanDong) Co., Ltd., received the "Approval Notice for the Listing Application of Chemical Raw Materials" issued by the National Medical Products Administration on December 20, 2024, granting approval for the listing application of L-Malic Acid. L-Malic Acid is widely used in drugs for liver dysfunction, uremia, hypertension, cancer, heart disease, etc. Adding L-Malic Acid to medications can enhance their stability and promote absorption and Diffusion in the body, while L-Malic Acid can also reduce the toxic effects of anticancer drugs on normal cells.
Jointown Pharmaceutical Group to Cut Jiuzhoutong Pharmaceutical Investment's Capital to 526 Million Yuan
Jointown Pharmaceutical Plans Transfer of Assets in Shanghai, Hangzhou, Chongqing
Jointown Pharmaceutical Group (600998.SH): intends to reduce capital for Jointown Pharmaceutical Investment.
Gelonghui reported on December 17 that Jointown Pharmaceutical Group (600998.SH) announced that it will hold the twelfth meeting of the sixth Board of Directors on December 17, 2024, to review and approve the proposal regarding the reduction of capital for its wholly-owned subsidiary. The registered capital of Jointown Medical Investment is proposed to be reduced from 11,525.6089 million yuan to 525.6089 million yuan, while the company's shareholding ratio in Jointown Medical Investment will remain at 100%. This reduction in capital will not lead to any changes in the company's consolidated financial statement scope, main Business, Assets, income, etc.
Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Shares Lagging The Market But So Is The Business
No Data
